IP Library Granted Patent US 8,623,646
Granted Patent B2
US 8,623,646 · App. 13/035,504 · Granted Jan 7, 2014

Volume exclusion agent to enhance formation of extracellular matrix

Inventors: David E. Birk (Tampa, FL); John Hassell (Tampa, FL); Bradley Kane (Lakeland, FL); La Tia Etheredge (Tampa, FL)
Assignees: University of South Florida; Thomas Jefferson University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,623,646
App. No.
13/035,504
Granted
Jan 7, 2014
Kind
B2
Abstract

A method of enhancing the formation of extracellular matrix in culture. Cells in culture secrete most of the collagen into the media as unprocessed procollagen, i.e., the cells do not convert procollagen to collagen. In contrast, normal extracellular matrix deposition involves procollagen processing to collagen, fibril assembly and deposition into the cell layer to form a collagenous extracellular matrix. The addition of certain growth factors and the addition of a thin layer of a certain volume exclusion agent on top of the cells dramatically enhances the conversion of procollagen to collagen and will increase the amount of collagen and extracellular matrix associated with the cells. This invention advances bioengineering of connective tissues for medical applications that require an extensive and functional extracellular matrix with high tensile strength such as those in the cornea stroma, skin, tendons, ligaments, articular cartilage and the intervertebral disks.

Claims (36)

1. A method of enhancing the formation of extracellular matrices in culture comprising the steps of:

plating out fibroblast cells on a tissue culture substrate;

adding media containing a collagen synthesis stimulating growth factor to the plated cells;

incubating the plated cells to facilitate attachment of the cells to the tissue culture substrate;

removing the media from the substrate containing the growth factor stimulated cells;

adding a volume exclusion agent capable of converting procollagen to collagen on top of the plated fibroblast cells wherein the volume exclusion agent is a hydrogel wherein the hydrogel creates a semipermeable barrier on the top of the plated fibroblast cells;

adding tissue culture media containing the collagen synthesis stimulating growth factor on top of the hydrogel; and

incubating the plated fibroblast cells in a tissue culture incubator;

whereby after incubation procollagen is converted to collagen and extracellular matrices are formed.

2. The method according to claim 1 , wherein the volume exclusion agent is an agarose overlay.

3. The method according to claim 2 , wherein the agarose overlay is between a 1%-6% solution of low melting temperature agarose in distilled water mixed with an equal volume of media containing the collagen synthesis stimulating growth factor.

4. The method according to claim 1 wherein the fibroblast cells are selected from the group consisting of keratocytes, and tenocytes.

5. A method of enhancing the formation of extracellular collagen matrices in culture by increasing the conversion of procollagen to collagen comprising the steps of:

plating out keratocytes on a tissue culture substrate;

adding a volume exclusion agent capable of converting procollagen to collagen on top of the plated keratocytes wherein the volume exclusion agent is a hydrogel wherein the hydrogel creates a semipermeable barrier on the top of the plated keratocytes;

adding tissue culture media containing a collagen synthesis stimulating growth factor to the substrate containing the overlaid plated keratocytes; and

incubating the plated keratocytes in a tissue culture incubator

whereby after incubation procollagen is converted to collagen and extracellular collagen matrices are formed.

6. The method according to claim 5 , wherein the volume exclusion agent is an agarose overlay.

7. The method according to claim 6 , wherein the agarose overlay is between a 1%-6% solution of low melting temperature agarose in distilled water.

8. A method of enhancing the formation of extracellular matrices in culture by increasing the conversion of procollagen to collagen comprising the steps of:

plating out keratocytes on a tissue culture substrate;

adding media containing a collagen synthesis stimulating growth factor to the plated keratocytes;

incubating the plated keratocytes to facilitate attachment of the keratocytes to the tissue culture substrate;

removing the media from the substrate containing the growth factor stimulated keratocytes;

adding a hydrogel overlay capable of converting procollagen to collagen on top of the plated keratocytes wherein the hydrogel creates a semipermeable barrier on the top of the plated keratocytes;

adding tissue culture media containing the growth factor to the substrate containing the overlaid plated keratocytes; and

incubating the plated keratocytes in a tissue culture incubator;

whereby after incubation procollagen is converted to collagen and extracellular collagen matrices are formed.

9. The method according to claim 8 , wherein the growth factor is insulin.

10. The method of claim 1 , wherein the growth factor is selected from the group consisting of IGF-I, PDGF, TGF-β and insulin.

11. The method of claim 1 , wherein the volume exclusion agent is a hydrogel selected from the group consisting of agarose, kappa-carrageenan, iota-carrageenan, gelatin, elastin-mimetic protein polymers and silk-elastin block copolymers.

12. The method of claim 5 , wherein the growth factor is selected from the group consisting of IGF-I, PDGF, TGF-β and insulin.

13. The method of claim 5 , wherein the volume exclusion agent is a hydrogel selected from the group consisting of agarose, kappa-carrageenan, iota-carrageenan, gelatin, elastin-mimetic protein polymers and silk-elastin block copolymers.

14. The method of claim 8 , wherein the growth factor is selected from the group consisting of IGF-I, PDGF, TGF-β and insulin.

15. The method of claim 8 , wherein the volume exclusion agent is a hydrogel selected from the group consisting of agarose, kappa-carrageenan, iota-carrageenan, gelatin, elastin-mimetic protein polymers and silk-elastin block copolymers.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 22, 2016
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040665/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2011
From: HASSELL, JOHN; KANE, BRADLEY; ETHEREDGE, LA TIA
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 026646/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2011
From: BIRK, DAVID E.
To: THOMAS JEFFERSON UNIVERSITY; UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 026135/0609 →
Continuity (3)
Continuation PCTUS2009054899 · Aug 25, 2009
Provisional Application 61091584 · Aug 25, 2008
Related Publication 20110244570A1 · Oct 6, 2011